InvestorsHub Logo
Followers 1054
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: buckiii2 post# 20003

Tuesday, 09/27/2016 12:50:13 PM

Tuesday, September 27, 2016 12:50:13 PM

Post# of 23979
KTOV thanks buckiii2,and KIT-302 beats Pfizer's drug.Today, there is no drug on the market that handles both things together - in pain as a result of osteoarthritis and high blood pressure. Therefore, the KIT-302 will be the only drug with indication for the treatment of pain while reducing the risk of heart attack and stroke may even brought a dying patient.

40% of docs "will prescribe over Celebrex",25 percent of doc's that won't RX Celebrex would RX KIT.

I think a BO on the table too(I would say 300m the least imo for a billion dollar drug. vs 24m current cap).

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.